The market may be wrong here because they amended the agreement with Hologic (formerly Gen-Probe) which reduces the $10M they were obligated to pay down to $2.5M. So that takes a lot of liability off the books which should allow them to use the whole $15M more or less left after the $2.5M is gone to distribute to shareholders.
News 
Market Data 
Discover 
